Latest IKT reports update at 2024-05-15: 2024-Q12023-Q42023-Q1
Inhibikase Therapeutics logo
Inhibikase Therapeutics IKT
$ 1.84 1.66%

Inhibikase Therapeutics EV - Enterprise Value 2011-2024 | IKT

Annual EV - Enterprise Value Inhibikase Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.62 M -37.3 K -17.4 M 40.7 M 4.53 M 3.62 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
40.7 M -17.4 M 6.35 M